Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:48 UTC |
---|
HMDB ID | HMDB0014958 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Tadalafil |
---|
Description | Tadalafil is an orally adminstered drug used to treat male erectile dysfunction (impotence). It is marketed worldwide under the brand name Cialis. It is a phosphodiesterase 5 (PDE5) inhibitor. Tadalafil's distinguishing pharmacologic feature is its longer half-life (17.5 hours) compared with Viagra and Levitra (4-5 hours). This longer half-life results in a longer duration of action and is, in part, responsible for the Cialis nickname of the 'weekend pill.' This longer half-life also is the basis of current investigation for tadalafil's use in pulmonary arterial hypertension as a once-daily therapy. [Wikipedia ] |
---|
Structure | [H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1 InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione | ChEBI | (6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione | ChEBI | 6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione | ChEBI | Adcirca | ChEBI | Cialis | ChEBI | Zalutia | Kegg | ICOS 351 | HMDB | Tadanafil | HMDB | 351, IC | HMDB |
|
---|
Chemical Formula | C22H19N3O4 |
---|
Average Molecular Weight | 389.404 |
---|
Monoisotopic Molecular Weight | 389.137556111 |
---|
IUPAC Name | (2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),11,13,15-tetraene-4,7-dione |
---|
Traditional Name | tadalafil |
---|
CAS Registry Number | 171596-29-5 |
---|
SMILES | [H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1 |
---|
InChI Identifier | InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1 |
---|
InChI Key | WOXKDUGGOYFFRN-IIBYNOLFSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as beta carbolines. Beta carbolines are compounds containing a 9H-pyrido[3,4-b]indole moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Pyridoindoles |
---|
Direct Parent | Beta carbolines |
---|
Alternative Parents | |
---|
Substituents | - Beta-carboline
- Alpha-amino acid or derivatives
- 3-alkylindole
- Benzodioxole
- Indole
- 2,5-dioxopiperazine
- Dioxopiperazine
- N-methylpiperazine
- N-alkylpiperazine
- Benzenoid
- Piperazine
- 1,4-diazinane
- Tertiary carboxylic acid amide
- Pyrrole
- Heteroaromatic compound
- Carboxamide group
- Lactam
- Acetal
- Carboxylic acid derivative
- Oxacycle
- Azacycle
- Hydrocarbon derivative
- Organic nitrogen compound
- Organic oxide
- Carbonyl group
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 301 - 302 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.25 g/L | Not Available | LogP | 1.7 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross SectionsAdduct Type | Data Source | CCS Value (Å2) | Reference |
---|
[M+H]+ | CBM | 189.4 | 30932474 |
|
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Tadalafil,1TMS,isomer #1 | CN1CC(=O)N2[C@H](CC3=C([C@H]2C2=CC=C4OCOC4=C2)N([Si](C)(C)C)C2=CC=CC=C32)C1=O | 3619.5 | Semi standard non polar | 33892256 | Tadalafil,1TMS,isomer #1 | CN1CC(=O)N2[C@H](CC3=C([C@H]2C2=CC=C4OCOC4=C2)N([Si](C)(C)C)C2=CC=CC=C32)C1=O | 3613.8 | Standard non polar | 33892256 | Tadalafil,1TMS,isomer #1 | CN1CC(=O)N2[C@H](CC3=C([C@H]2C2=CC=C4OCOC4=C2)N([Si](C)(C)C)C2=CC=CC=C32)C1=O | 4812.1 | Standard polar | 33892256 | Tadalafil,1TBDMS,isomer #1 | CN1CC(=O)N2[C@H](CC3=C([C@H]2C2=CC=C4OCOC4=C2)N([Si](C)(C)C(C)(C)C)C2=CC=CC=C32)C1=O | 3799.5 | Semi standard non polar | 33892256 | Tadalafil,1TBDMS,isomer #1 | CN1CC(=O)N2[C@H](CC3=C([C@H]2C2=CC=C4OCOC4=C2)N([Si](C)(C)C(C)(C)C)C2=CC=CC=C32)C1=O | 3866.6 | Standard non polar | 33892256 | Tadalafil,1TBDMS,isomer #1 | CN1CC(=O)N2[C@H](CC3=C([C@H]2C2=CC=C4OCOC4=C2)N([Si](C)(C)C(C)(C)C)C2=CC=CC=C32)C1=O | 4838.0 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Tadalafil GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-3097000000-803ff86b2ce502e2bc83 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tadalafil GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tadalafil GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil LC-ESI-qTof , Positive-QTOF | splash10-02t9-2890000000-0be3708ad44a8a467cc5 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil Linear Ion Trap , negative-QTOF | splash10-03di-0090000000-c52485d22b5893fc60a2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil Linear Ion Trap , negative-QTOF | splash10-03di-0090000000-2f6ad2194cd2932b0761 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil Linear Ion Trap , positive-QTOF | splash10-0i0r-0291000000-a4ae40141abccfc86710 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil Linear Ion Trap , positive-QTOF | splash10-0j59-0290000000-86095fe2d98833db9d0b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil Linear Ion Trap , positive-QTOF | splash10-0uy0-0429200000-641774545afc89315134 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil Linear Ion Trap , positive-QTOF | splash10-0uy0-0429200000-f223c860e93cceeeacd8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil , positive-QTOF | splash10-014i-0292000000-0563bdd5b0be8c1cfa47 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil , positive-QTOF | splash10-02t9-2890000000-0be3708ad44a8a467cc5 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 35V, Positive-QTOF | splash10-014i-0391000000-2d53d99ea189cbcf20bf | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 10V, Positive-QTOF | splash10-0f6x-0009000000-bea170f3de4098be75e0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 40V, Positive-QTOF | splash10-001i-0191000000-b10465a3e1f68719ab50 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 20V, Positive-QTOF | splash10-0udi-0019000000-989b326813e322333fa5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 20V, Negative-QTOF | splash10-004i-0119000000-28b2b617eb618183d5c8 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 40V, Negative-QTOF | splash10-001i-0791000000-5534e9b8d8ed5169e623 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 10V, Negative-QTOF | splash10-000i-0009000000-844cd3bb8e0273b1cadd | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 35V, Negative-QTOF | splash10-03di-0091000000-612762fb281177438c8e | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 10V, Positive-QTOF | splash10-0006-0009000000-cfa5abcf4ec76ea41d68 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 20V, Positive-QTOF | splash10-0006-1019000000-59cc81b34404c6ecd167 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 40V, Positive-QTOF | splash10-0006-0291000000-20d1a51d47c7345d5742 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 10V, Negative-QTOF | splash10-000i-2009000000-721840625f2b26eb19a7 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 20V, Negative-QTOF | splash10-052r-4019000000-5dff72997668963ef319 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 40V, Negative-QTOF | splash10-01pc-2191000000-f8bd70ef77444b35f09b | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 10V, Positive-QTOF | splash10-0006-0029000000-5ec0e4346a39de6e6582 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 20V, Positive-QTOF | splash10-0006-0009000000-565961b51e5cb53f55d4 | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|